Patent · US Expired

Use of diphenylbutyl-piperazinecarboxamides in the treatment of substance disorders

US5618817A · kind A · utility

2Cited by

4References

6Claims

0Family size

Assignee

Kabi Pharmacia AB · SE

Inventors

Anders Bjork · Bjärred, SE
Erik G. Christensson · Lund, SE

Key dates

Filing date	Apr 25, 1995
Grant date	Apr 8, 1997
Priority date	—
Expiry date	Apr 25, 2015

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P39/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the relief or prevention of withdrawal syndrome resulting from addiction to non-opiate type drugs of abuse and/or the suppression of dependence on non-opiate type drugs of abuse by administering to a person in need thereof, an effective amount of certain diphenylbutyl-piperazine-carboxamides including 4-[4,4-bis(4-fluorophenyl)butyl]-N-ethyl-1-piperazine-carboxamide which is known as amperozide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.